Medical College of Wisconsin
CTSICores SearchResearch InformaticsREDCap

Ben George MD

Ben George MD profile photo picture

Associate Professor

Institution: Medical College of Wisconsin
Department: Medicine
Division: Hematology and Oncology - Medicine
Program: Hematology

Member of the Cancer Center
Member of the Genomic Sciences and Precision Medicine Center (GSPMC)


Publications (49)

  • Open-label, Phase I Study of Nivolumab Combined with nab-Paclitaxel Plus Gemcitabine in Advanced Pancreatic Cancer. (Wainberg ZA, Hochster HS, Kim EJ, George B, Kaylan A, Chiorean EG, Waterhouse DM, Guiterrez M, Parikh A, Jain R, Carrizosa DR, Soliman HH, Lila T, Reiss DJ, Pierce DW, Bhore R, Banerjee S, Lyons L, Louis CU, Ong TJ, O'Dwyer PJ) Clin Cancer Res 2020 Sep 15;26(18):4814-4822 PMID: 32554514 06/20/2020    
  • Value of Pretreatment 18F-fluorodeoxyglucose Positron Emission Tomography in Patients With Localized Pancreatic Cancer Treated With Neoadjuvant Therapy. (Barnes CA, Aldakkak M, Clarke CN, Christians KK, Bucklan D, Holt M, Tolat P, Ritch PS, George B, Hall WA, Erickson BA, Evans DB, Tsai S) Front Oncol 2020;10:500 PMID: 32363161 PMCID: PMC7180175 SCOPUS ID: 2-s2.0-85084152103 05/05/2020    
  • Detection of germline variants using expanded multigene panels in patients with localized pancreatic cancer. (Krepline AN, Geurts JL, Akinola I, Christians KK, Clarke CN, George B, Ritch PS, Khan AH, Hall WA, Erickson BA, Griffin MO, Evans DB, Tsai S) HPB (Oxford) 2020 Apr 27 PMID: 32354656 05/02/2020    
  • Impact of Neoadjuvant Chemoradiation on Pathologic Response in Patients With Localized Pancreatic Cancer. (Wittmann D, Hall WA, Christians KK, Barnes CA, Jariwalla NR, Aldakkak M, Clarke CN, George B, Ritch PS, Riese M, Khan AH, Kulkarni N, Evans J, Erickson BA, Evans DB, Tsai S) Front Oncol 2020;10:460 PMID: 32351886 PMCID: PMC7175033 SCOPUS ID: 2-s2.0-85084010622 05/01/2020    
  • Role of Molecular Profiling of Pancreatic Cancer After Neoadjuvant Therapy: Does it Change Practice? (Krepline AN, Bliss L, Geurts J, Akinola I, Christians KK, George B, Ritch PS, Hall WA, Erickson BA, Evans DB, Tsai S) J Gastrointest Surg 2020 Feb;24(2):235-242 PMID: 31745905 SCOPUS ID: 2-s2.0-85076028351 11/21/2019    
  • Management of Acute Cholecystitis during Neoadjuvant Therapy in Patients with Pancreatic Adenocarcinoma. (Jariwalla NR, Khan AH, Dua K, Christians KK, Clarke CN, Aldakkak M, George B, Tutton S, Rilling W, Erickson B, Evans DB, Tsai S) Ann Surg Oncol 2019 Dec;26(13):4515-4521 PMID: 31641946 SCOPUS ID: 2-s2.0-85074492297 10/24/2019    
  • Efficacy and Safety of Trifluridine/Tipiracil Treatment in Patients With Metastatic Gastric Cancer Who Had Undergone Gastrectomy: Subgroup Analyses of a Randomized Clinical Trial. (Ilson DH, Tabernero J, Prokharau A, Arkenau HT, Ghidini M, Fujitani K, Van Cutsem E, Thuss-Patience P, Beretta GD, Mansoor W, Zhavrid E, Alsina M, George B, Catenacci D, McGuigan S, Makris L, Doi T, Shitara K) JAMA Oncol 2019 Oct 10 PMID: 31600365 PMCID: PMC6802061 10/11/2019       4 Citations
  • Molecular and Genetic Markers in Appendiceal Mucinous Tumors: A Systematic Review. (Stein A, Strong E, Clark Gamblin T, Clarke C, Tsai S, Thomas J, George B, Mogal H) Ann Surg Oncol 2020 Jan;27(1):85-97 PMID: 31583543 SCOPUS ID: 2-s2.0-85074461946 10/05/2019       3 Citations
  • Survival of patients with borderline resectable pancreatic cancer who received neoadjuvant therapy and surgery. (Barnes CA, Chavez MI, Tsai S, Aldakkak M, George B, Ritch PS, Dua K, Clarke CN, Tolat P, Hagen C, Hall WA, Erickson BA, Evans DB, Christians KK) Surgery 2019 09;166(3):277-285 PMID: 31272811 SCOPUS ID: 2-s2.0-85068174272 07/06/2019       3 Citations
  • Etanercept for Treatment of Taxane-Induced Pneumonitis. (Singavi AK, Ramalingam V, George B) J Oncol Pract 2019 10;15(10):556-557 PMID: 31219735 SCOPUS ID: 2-s2.0-85073126372 06/21/2019       1 Citation
  • Downstaging Locally Advanced Cholangiocarcinoma Pre-Liver Transplantation: A¬†Prospective Pilot Study. (Wong M, Kim J, George B, Eriksen C, Pearson T, Robbins J, Zimmerman MA, Hong JC) J Surg Res 2019 10;242:23-30 PMID: 31059945 SCOPUS ID: 2-s2.0-85065040956 05/07/2019       3 Citations
  • Real-Time Targeted Genome Profile Analysis of Pancreatic Ductal Adenocarcinomas Identifies Genetic Alterations That Might Be Targeted With Existing Drugs or Used as Biomarkers. (Singhi AD, George B, Greenbowe JR, Chung J, Suh J, Maitra A, Klempner SJ, Hendifar A, Milind JM, Golan T, Brand RE, Zureikat AH, Roy S, Schrock AB, Miller VA, Ross JS, Ali SM, Bahary N) Gastroenterology 2019 06;156(8):2242-2253.e4 PMID: 30836094 03/06/2019       22 Citations
  • Proliferative potential and resistance to immune checkpoint blockade in lung cancer patients. (Pabla S, Conroy JM, Nesline MK, Glenn ST, Papanicolau-Sengos A, Burgher B, Hagen J, Giamo V, Andreas J, Lenzo FL, Yirong W, Dy GK, Yau E, Early A, Chen H, Bshara W, Madden KG, Shirai K, Dragnev K, Tafe LJ, Marin D, Zhu J, Clarke J, Labriola M, McCall S, Zhang T, Zibelman M, Ghatalia P, Araujo-Fernandez I, Singavi A, George B, MacKinnon AC, Thompson J, Singh R, Jacob R, Dressler L, Steciuk M, Binns O, Kasuganti D, Shah N, Ernstoff M, Odunsi K, Kurzrock R, Gardner M, Galluzzi L, Morrison C) J Immunother Cancer 2019 02 01;7(1):27 PMID: 30709424 PMCID: PMC6359802 SCOPUS ID: 2-s2.0-85060929943 02/03/2019       12 Citations
  • Next generation sequencing of PD-L1 for predicting response to immune checkpoint inhibitors. (Conroy JM, Pabla S, Nesline MK, Glenn ST, Papanicolau-Sengos A, Burgher B, Andreas J, Giamo V, Wang Y, Lenzo FL, Bshara W, Khalil M, Dy GK, Madden KG, Shirai K, Dragnev K, Tafe LJ, Zhu J, Labriola M, Marin D, McCall SJ, Clarke J, George DJ, Zhang T, Zibelman M, Ghatalia P, Araujo-Fernandez I, de la Cruz-Merino L, Singavi A, George B, MacKinnon AC, Thompson J, Singh R, Jacob R, Kasuganti D, Shah N, Day R, Galluzzi L, Gardner M, Morrison C) J Immunother Cancer 2019 01 24;7(1):18 PMID: 30678715 PMCID: PMC6346512 SCOPUS ID: 2-s2.0-85060525068 01/27/2019       18 Citations
  • Immunogenomic Landscape Contributes to Hyperprogressive Disease after Anti-PD-1 Immunotherapy for Cancer. (Xiong D, Wang Y, Singavi AK, Mackinnon AC, George B, You M) iScience 2018 Nov 30;9:258-277 PMID: 30439581 PMCID: PMC6234258 11/16/2018    
  • Importance of Normalization of CA19-9 Levels Following Neoadjuvant Therapy in Patients With Localized Pancreatic Cancer. (Tsai S, George B, Wittmann D, Ritch PS, Krepline AN, Aldakkak M, Barnes CA, Christians KK, Dua K, Griffin M, Hagen C, Hall WA, Erickson BA, Evans DB) Ann Surg 2020 04;271(4):740-747 PMID: 30312198 SCOPUS ID: 2-s2.0-85082099572 10/13/2018       16 Citations
  • Characteristics of Late Fatal Infections after Allogeneic Hematopoietic Cell Transplantation. (Norkin M, Shaw BE, Brazauskas R, Tecca HR, Leather HL, Gea-Banacloche J, T Kamble R, DeFilipp Z, Jacobsohn DA, Ringden O, Inamoto Y, A Kasow K, Buchbinder D, Shaw P, Hematti P, Schears R, Badawy SM, Lazarus HM, Bhatt N, Horn B, Chhabra S, M Page K, Hamilton B, Hildebrandt GC, Yared JA, Agrawal V, M Beitinjaneh A, Majhail N, Kindwall-Keller T, Olsson RF, Schoemans H, Gale RP, Ganguly S, A Ahmed I, Schouten HC, L Liesveld J, Khera N, Steinberg A, Shah AJ, Solh M, Marks DI, Rybka W, Aljurf M, Dietz AC, Gergis U, George B, Seo S, Flowers MED, Battiwalla M, Savani BN, Riches ML, Wingard JR) Biol Blood Marrow Transplant 2019 02;25(2):362-368 PMID: 30287390 PMCID: PMC6339825 SCOPUS ID: 2-s2.0-85055972080 10/06/2018       4 Citations
  • A Phase II Clinical Trial of Molecular Profiled Neoadjuvant Therapy for Localized Pancreatic Ductal Adenocarcinoma. (Tsai S, Christians KK, George B, Ritch PS, Dua K, Khan A, Mackinnon AC, Tolat P, Ahmad SA, Hall WA, Erickson BA, Evans DB) Ann Surg 2018 10;268(4):610-619 PMID: 30080723 SCOPUS ID: 2-s2.0-85067054610 08/07/2018       16 Citations
  • Locally advanced pancreas cancer: Staging and goals of therapy. (Chatzizacharias NA, Tsai S, Griffin M, Tolat P, Ritch P, George B, Barnes C, Aldakkak M, Khan AH, Hall W, Erickson B, Evans DB, Christians KK) Surgery 2018 05;163(5):1053-1062 PMID: 29331400 SCOPUS ID: 2-s2.0-85040254084 01/15/2018       11 Citations
  • Comprehensive Analysis of Hypermutation in Human Cancer. (Campbell BB, Light N, Fabrizio D, Zatzman M, Fuligni F, de Borja R, Davidson S, Edwards M, Elvin JA, Hodel KP, Zahurancik WJ, Suo Z, Lipman T, Wimmer K, Kratz CP, Bowers DC, Laetsch TW, Dunn GP, Johanns TM, Grimmer MR, Smirnov IV, Larouche V, Samuel D, Bronsema A, Osborn M, Stearns D, Raman P, Cole KA, Storm PB, Yalon M, Opocher E, Mason G, Thomas GA, Sabel M, George B, Ziegler DS, Lindhorst S, Issai VM, Constantini S, Toledano H, Elhasid R, Farah R, Dvir R, Dirks P, Huang A, Galati MA, Chung J, Ramaswamy V, Irwin MS, Aronson M, Durno C, Taylor MD, Rechavi G, Maris JM, Bouffet E, Hawkins C, Costello JF, Meyn MS, Pursell ZF, Malkin D, Tabori U, Shlien A) Cell 2017 Nov 16;171(5):1042-1056.e10 PMID: 29056344 PMCID: PMC5849393 10/24/2017       223 Citations
  • Should functional renal scans be obtained prior to upper abdominal IMRT for pancreatic cancer? (Blitzer GC, Hall WA, Tsai S, Aldakkak M, Hellman RS, Evans DB, Christians KK, George B, Ritch PS, Erickson BA) Pract Radiat Oncol 2017 Nov - Dec;7(6):e449-e455 PMID: 28886941 SCOPUS ID: 2-s2.0-85028763165 09/10/2017    
  • Is Adjuvant Therapy Necessary for All Patients with Localized Pancreatic Cancer Who Have Received Neoadjuvant Therapy? (Barnes CA, Krepline AN, Aldakkak M, Clarke CN, Christians KK, Khan AH, Hunt BC, Ritch PS, George B, Hall WA, Erickson BA, Evans DB, Tsai S) J Gastrointest Surg 2017 Nov;21(11):1793-1803 PMID: 28849366 SCOPUS ID: 2-s2.0-85028529403 08/30/2017       8 Citations
  • Poor Glycemic Control Is Associated with Failure to Complete Neoadjuvant Therapy and Surgery in Patients with Localized Pancreatic Cancer. (Rajamanickam ES, Christians KK, Aldakkak M, Krepline AN, Ritch PS, George B, Erickson BA, Foley WD, Aburajab M, Evans DB, Tsai S) J Gastrointest Surg 2017 03;21(3):496-505 PMID: 27896658 SCOPUS ID: 2-s2.0-84997795492 11/30/2016       1 Citation
  • Multimodality Therapy in Patients With Borderline Resectable or Locally Advanced Pancreatic Cancer: Importance of Locoregional Therapies for a Systemic Disease. (Tsai S, Christians KK, Ritch PS, George B, Khan AH, Erickson B, Evans DB) J Oncol Pract 2016 10;12(10):915-923 PMID: 27858562 SCOPUS ID: 2-s2.0-84991252464 11/20/2016       10 Citations
  • Venous thromboembolism prophylaxis during neoadjuvant therapy for resectable and borderline resectable pancreatic cancer-Is it indicated? (Krepline AN, Christians KK, George B, Ritch PS, Erickson BA, Tolat P, Evans DB, Tsai S) J Surg Oncol 2016 Oct;114(5):581-586 PMID: 27760280 SCOPUS ID: 2-s2.0-84992111849 10/22/2016       12 Citations
  • High-Grade Neuroendocrine Colorectal Carcinomas: A Retrospective Study of 100 Patients. (Conte B, George B, Overman M, Estrella J, Jiang ZQ, Mehrvarz Sarshekeh A, Ferrarotto R, Hoff PM, Rashid A, Yao JC, Kopetz S, Dasari A) Clin Colorectal Cancer 2016 Jun;15(2):e1-7 PMID: 26810202 PMCID: PMC4885752 01/27/2016       16 Citations
  • Survival of patients with resectable pancreatic cancer who received neoadjuvant therapy. (Christians KK, Heimler JW, George B, Ritch PS, Erickson BA, Johnston F, Tolat PP, Foley WD, Evans DB, Tsai S) Surgery 2016 Mar;159(3):893-900 PMID: 26602840 SCOPUS ID: 2-s2.0-84950987094 11/26/2015       66 Citations
  • Comparative Effectiveness of Hepatic Artery Based Therapies for Unresectable Colorectal Liver Metastases: A Meta-Analysis. (Zacharias AJ, Jayakrishnan TT, Rajeev R, Rilling WS, Thomas JP, George B, Johnston FM, Gamblin TC, Turaga KK) PLoS One 2015;10(10):e0139940 PMID: 26448327 PMCID: PMC4598149 SCOPUS ID: 2-s2.0-84948706797 10/09/2015       17 Citations
  • Neoadjuvant therapy for localized pancreatic cancer: guiding principles. (Fathi A, Christians KK, George B, Ritch PS, Erickson BA, Tolat P, Johnston FM, Evans DB, Tsai S) J Gastrointest Oncol 2015 Aug;6(4):418-29 PMID: 26261728 PMCID: PMC4502155 08/12/2015    
  • Pre-treatment carbohydrate antigen 19-9 does not predict the response to neoadjuvant therapy in patients with localized pancreatic cancer. (Aldakkak M, Christians KK, Krepline AN, George B, Ritch PS, Erickson BA, Johnston FM, Evans DB, Tsai S) HPB (Oxford) 2015 Oct;17(10):942-52 PMID: 26255895 PMCID: PMC4571763 SCOPUS ID: 2-s2.0-84941878704 08/11/2015       21 Citations
  • Use of neoadjuvant therapy in patients 75 years of age and older with pancreatic cancer. (Miura JT, Krepline AN, George B, Ritch PS, Erickson BA, Johnston FM, Oshima K, Christians KK, Evans DB, Tsai S) Surgery 2015 Dec;158(6):1545-55 PMID: 26243342 SCOPUS ID: 2-s2.0-84947023760 08/06/2015       18 Citations
  • Non-metastatic Pancreatic Cancer: Resectable, Borderline Resectable, and Locally Advanced-Definitions of Increasing Importance for the Optimal Delivery of Multimodality Therapy. (Evans DB, George B, Tsai S) Ann Surg Oncol 2015 Oct;22(11):3409-13 PMID: 26122369 SCOPUS ID: 2-s2.0-84941417302 07/01/2015       42 Citations
  • An Unusual Combination: KRAS and BRAF Co-mutated Metastatic Colorectal Cancer. (Epperla N, George B) J Gastrointest Cancer 2016 Jun;47(2):206-9 PMID: 26018827 05/29/2015    
  • Chemotherapy for Surgically Resected Intrahepatic Cholangiocarcinoma. (Miura JT, Johnston FM, Tsai S, George B, Thomas J, Eastwood D, Banerjee A, Christians KK, Turaga KK, Pawlik TM, Clark Gamblin T) Ann Surg Oncol 2015 Oct;22(11):3716-23 PMID: 25777092 SCOPUS ID: 2-s2.0-84941418828 03/18/2015       49 Citations
  • Acute Onset of Acrokeratosis Paraneoplastica (Bazex Syndrome). (Humphrey SR, Hussain AS, Chandran R, Wilson B, George B) JAMA Dermatol 2015 Jun;151(6):677-8 PMID: 25760248 SCOPUS ID: 2-s2.0-84931096695 03/12/2015       4 Citations
  • Neoadjuvant chemoradiation with IMRT in resectable and borderline resectable pancreatic cancer. (Kharofa J, Tsai S, Kelly T, Wood C, George B, Ritch P, Wiebe L, Christians K, Evans DB, Erickson B) Radiother Oncol 2014 Oct;113(1):41-6 PMID: 25443499 PMCID: PMC4530020 SCOPUS ID: 2-s2.0-84922745297 12/03/2014       31 Citations
  • Patency rates of portal vein/superior mesenteric vein reconstruction after pancreatectomy for pancreatic cancer. (Krepline AN, Christians KK, Duelge K, Mahmoud A, Ritch P, George B, Erickson BA, Foley WD, Quebbeman EJ, Turaga KK, Johnston FM, Gamblin TC, Evans DB, Tsai S) J Gastrointest Surg 2014 Nov;18(11):2016-25 PMID: 25227638 SCOPUS ID: 2-s2.0-84920138622 09/18/2014       24 Citations
  • Diagnostic laparoscopy should be performed before definitive resection for pancreatic cancer: a financial argument. (Jayakrishnan TT, Nadeem H, Groeschl RT, George B, Thomas JP, Ritch PS, Christians KK, Tsai S, Evans DB, Pappas SG, Gamblin TC, Turaga KK) HPB (Oxford) 2015 Feb;17(2):131-9 PMID: 25123702 PMCID: PMC4299387 SCOPUS ID: 2-s2.0-84920841239 08/16/2014       13 Citations
  • Molecular profiling in gastric cancer: examining potential targets for chemotherapy. (Miura JT, Johnston FM, Thomas J, George B, Eastwood D, Tsai S, Christians KK, Turaga KK, Gamblin TC) J Surg Oncol 2014 Sep;110(3):302-6 PMID: 24844210 SCOPUS ID: 2-s2.0-84905367494 05/23/2014       9 Citations
  • Arterial resection at the time of pancreatectomy for cancer. (Christians KK, Pilgrim CH, Tsai S, Ritch P, George B, Erickson B, Tolat P, Evans DB) Surgery 2014 May;155(5):919-26 PMID: 24787115 SCOPUS ID: 2-s2.0-84899659181 05/03/2014       58 Citations
  • Systematic review of outcomes of patients undergoing resection for colorectal liver metastases in the setting of extra hepatic disease. (Hwang M, Jayakrishnan TT, Green DE, George B, Thomas JP, Groeschl RT, Erickson B, Pappas SG, Gamblin TC, Turaga KK) Eur J Cancer 2014 Jul;50(10):1747-1757 PMID: 24767470 SCOPUS ID: 2-s2.0-84901752316 04/29/2014       51 Citations
  • Management of acute cholecystitis in cancer patients: a comparative effectiveness approach. (Jayakrishnan TT, Groeschl RT, George B, Thomas JP, Pappas S, Gamblin TC, Turaga KK) Surg Endosc 2014 May;28(5):1505-14 PMID: 24687416 SCOPUS ID: 2-s2.0-84900328041 04/02/2014       5 Citations
  • Neoadjuvant FOLFIRINOX for borderline resectable pancreas cancer: a new treatment paradigm? (Christians KK, Tsai S, Mahmoud A, Ritch P, Thomas JP, Wiebe L, Kelly T, Erickson B, Wang H, Evans DB, George B) Oncologist 2014 Mar;19(3):266-74 PMID: 24569947 PMCID: PMC3958454 SCOPUS ID: 2-s2.0-84896486447 02/27/2014       138 Citations
  • Review of the impact of antineoplastic therapies on the risk for cholelithiasis and acute cholecystitis. (Jayakrishnan TT, Groeschl RT, George B, Thomas JP, Clark Gamblin T, Turaga KK) Ann Surg Oncol 2014 Jan;21(1):240-7 PMID: 24114054 SCOPUS ID: 2-s2.0-84891708354 10/12/2013       8 Citations
  • Ciliated hepatic cyst leading to squamous cell carcinoma of the liver - A case report and review of the literature. (Wilson JM, Groeschl R, George B, Turaga KK, Patel PJ, Saeian K, Gamblin TC) Int J Surg Case Rep 2013;4(11):972-5 PMID: 24055921 PMCID: PMC3825928 09/24/2013    
  • Survival benefit associated with surgical oophorectomy in patients with colorectal cancer metastatic to the ovary. (Garrett CR, George B, Viswanathan C, Bhadkamkar NA, Wen S, Baladandayuthapani V, You YN, Kopetz ES, Overman MJ, Kee BK, Eng C) Clin Colorectal Cancer 2012 Sep;11(3):191-4 PMID: 22280844 01/28/2012    
  • Predictive and prognostic markers in colorectal cancer. (George B, Kopetz S) Curr Oncol Rep 2011 Jun;13(3):206-15 PMID: 21373987 03/05/2011       33 Citations
  • Posterior reversible encephalopathy syndrome as a consequence of high dose steroid administration after autologous PBSCT. (Sukumaran S, George B, Nair HP, Drobyski WR) Bone Marrow Transplant 2010 Apr;45(4):779-80 PMID: 19684634 SCOPUS ID: 2-s2.0-77950629302 08/18/2009       4 Citations
  • Complete and durable response of choroid metastasis from non-small cell lung cancer with systemic bevacizumab and chemotherapy. (George B, Wirostko WJ, Connor TB, Choong NW) J Thorac Oncol 2009 May;4(5):661-2 PMID: 19395911 SCOPUS ID: 2-s2.0-67651159238 04/28/2009       27 Citations
  • Last update: 06/10/2020
    jenkins-FCD Prod-480 9a4deaf152b0b06dd18151814fff2e18f6c05280